Phosphorus

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: bones energy muscle

Research Overview

Across the provided abstracts, phosphorus research is most developed in three domains: (1) materials science and device engineering using black phosphorus (BP) and phosphorene, (2) biomedical and pharmaceutical chemistry focused on phosphorus-containing therapeutics, and (3) nutrition and physiology addressing dietary phosphorus, its interactions with other minerals, and health outcomes. In BP-based electronics, studies emphasize field-effect transistor optimization, stability engineering (e.g., element doping such as Te), and emerging sensing and therapeutic platforms. In biomedicine, work spans both small-molecule drug classes (e.g., phosphonates, bisphosphonates, phosphoramidates) and biomaterials that exploit BP degradation to phosphate for osteogenic effects. Nutritional research concentrates on intake sources (including dairy and phosphate additives), absorption/homeostasis across the life course, and interactions with compounds such as phytate that alter mineral bioavailability.

The strongest evidence in these abstracts supports several relatively mature conclusions. Experimentally, multilayer BP field-effect transistors can function as highly sensitive NO2 sensors (reported detection down to ppb levels), with adsorption behavior consistent with surface-coverage models (Langmuir isotherm) and measurable adsorption/desorption kinetics—indicating a quantitatively tractable sensing mechanism. In translational biomaterials, injectable BP nanosheet–containing hydrogels show proof-of-concept for combined photothermal therapy and chemotherapy with local tumor control and concurrent promotion of osteogenesis via phosphate release, at least in preclinical models. In human health, reviews converge on phosphorus as a key macromineral tightly regulated in concert with calcium and other electrolytes, while also highlighting that phosphorus-containing drugs constitute an established therapeutic class with diverse mechanisms and indications. Nutritional syntheses further suggest dairy contributes meaningfully to phosphorus intake without clear adverse associations with all-cause mortality in meta-analytic summaries, whereas increasing dietary phosphorus specifically via inorganic phosphate additives is linked to detrimental effects on bone/mineral metabolism, particularly relevant to chronic kidney disease management.

Key gaps remain. For BP technologies, priorities include improving ambient stability and long-term device reliability, expanding experimental validation beyond single analytes (e.g., selectivity and interference in real-world gas mixtures), and standardizing performance metrics for sensing and electronics. For BP-enabled therapeutics, more research is needed on degradation kinetics, phosphate release control, biodistribution, and long-term safety/toxicology to support clinical translation. In nutrition, the abstracts point to unresolved questions about bioavailability of phosphorus from different food matrices and functional foods, dose–response relationships and net clinical impact of phytate (benefits vs impaired mineral absorption), and stronger causal evidence on phosphate additives—especially across populations with altered mineral metabolism (e.g., CKD) and across life stages.

1. What conditions has Phosphorus been studied for?

  • Chronic kidney disease (CKD) and hyperphosphatemia-related outcomes: Reviews focus on dietary phosphorus intake as a determinant of serum phosphorus and its links to poor outcomes and mortality in CKD, including the role of hidden phosphorus sources and phosphate additives.

  • Bone and mineral metabolism / bone health: A review highlights effects of increasing dietary phosphorus (especially inorganic phosphate additives) on bone and mineral metabolism, and discusses whether lowering intake might affect fracture risk (evidence still developing).

  • Diabetes (as a dietary supplement ingredient): An automated literature review of common supplement ingredients found no studies meeting screening criteria supporting phosphorus supplements for improving diabetes outcomes.

  • Nutrition across the life cycle (general health): A macrominerals review discusses phosphorus roles, absorption, and homeostasis across fertility/pregnancy through older age, including interactions with other minerals.

  • Mineral bioavailability interactions via phytate: Clinical-trial-focused review of phytates (a major dietary form of plant phosphorus) examines beneficial and undesirable effects, including reduced absorption of minerals (e.g., calcium, iron, zinc).

  • Pharmaceutical/biomedical applications involving phosphorus chemistry (not dietary phosphorus): Reviews and studies describe phosphorus-containing drugs (multiple classes) and black-phosphorus-based biomedical platforms (e.g., osteosarcoma local therapy hydrogel; antidepressant nanocarrier). These are material/drug-delivery contexts rather than oral phosphorus supplementation.

2. Does it work in treating those conditions? Summarize the evidence.

  • CKD / high serum phosphorus: The abstracts support the concept that limiting dietary phosphorus—especially inorganic phosphate additives—can help control serum phosphate in CKD. One review notes “new data supporting an educational intervention to limit phosphate additives in patients with chronic kidney disease to control serum phosphate.” This is supportive but does not establish long-term clinical endpoints (e.g., mortality reduction) in the provided text.

  • Bone health (general population): Evidence summarized in the review suggests that increasing dietary phosphorus via inorganic phosphate additives has detrimental effects on bone and mineral metabolism in humans and animals. However, the same review states that further evidence is needed to confirm whether lowering dietary phosphorus improves fracture risk.

  • Diabetes (supplement use): The automated review found that several popular supplement ingredients, including phosphorus, “did not result in any studies meeting our screening criteria” for improving diabetes control. Based on that review, there is little to no clinical evidence supporting phosphorus supplements for diabetes management.

  • Osteosarcoma resection (local tumor control + bone repair) using black phosphorus nanosheets: In an injectable hydrogel study, a black-phosphorus-nanosheet/doxorubicin/chitosan hydrogel showed in vivo tumor elimination at the injection site without systemic toxicity and promoted osteogenic differentiation by releasing phosphate. This supports efficacy for that biomaterial platform, but it is not evidence that dietary phosphorus treats osteosarcoma.

  • Depression (hypericin delivery using black phosphorus nanosheets): A mouse study reports that a black-phosphorus-based targeted nanocarrier improved depressive-like behaviors and oxidative stress with “minimal adverse effects.” This supports the nanocarrier approach in animals, not phosphorus supplementation for depression.

3. What health benefits does it have?

  • Essential physiological roles: The macrominerals review states phosphorus is a macromineral with important roles in human health, including involvement in biochemical reactions and regulated absorption/homeostasis. Another abstract fragment notes phosphorus is essential and “pivotal for energy production” and functions in skeletal and non-skeletal tissues (statement is truncated but consistent with the abstract’s claim).

  • Contribution to nutrient adequacy via foods (e.g., dairy): The dairy evidence summary notes milk and dairy products contribute significantly to meeting requirements for multiple nutrients including phosphorus. The abstract overall supports adequate dairy intake across life stages and reports multiple health associations for dairy (though these benefits cannot be attributed to phosphorus alone).

  • Potential therapeutic utility in biomaterials (research context): In the osteosarcoma hydrogel study, black phosphorus nanosheets promoted osteogenic differentiation by releasing phosphate, suggesting a potential benefit for bone regeneration in a localized biomedical device context.

4. Does it have any downsides or side effects?

  • Excess intake—especially inorganic phosphate additives—may be harmful to bone/mineral metabolism: A dietary phosphorus review reports that increasing dietary phosphorus through inorganic phosphate additives has “detrimental effects on bone and mineral metabolism” in humans and animals. It also notes average intake in the USA is above the RDA and that additives are highly absorbed and likely underestimated.

  • CKD risk: high serum phosphorus linked to poor outcomes and mortality: A review states high serum phosphorus is linked to poor health outcomes and mortality in CKD patients (pre- or post-dialysis). This implies that excessive intake or hidden sources can be clinically important in CKD management.

  • Hidden/underestimated sources complicate safe intake: Another review emphasizes that phosphorus intake is often underestimated because databases may miss phosphate additives and phosphorus from supplements/medications, which can undermine dietary control—particularly relevant for CKD.

  • Phytate-related mineral absorption issues (dietary pattern context): The phytate review notes phytate can chelate cations (e.g., calcium, iron, zinc) and clinical studies show potential negative effects by reducing absorption of minerals important for homeostasis. This is not “phosphorus toxicity” per se, but it is a phosphorus-containing dietary compound that can adversely affect mineral status depending on diet and dose.

  • Biomedical black phosphorus platforms: The osteosarcoma hydrogel study reports no systemic toxicity in vivo, and the depression nanocarrier study reports minimal adverse effects in mice; however, these are specific engineered materials and do not establish long-term safety in humans.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The provided abstracts do not report pharmacogenomic findings (i.e., specific genetic variants that alter response, safety, or dosing) for dietary phosphorus, phosphate additives, or phosphorus-containing supplements.

  • No variant-specific evidence in these abstracts: The CKD, bone metabolism, phytate, and supplement/diabetes abstracts discuss population-level effects and exposure sources, not genotype-stratified outcomes.

  • Phosphorus-containing drugs: The review of phosphorus-containing drugs classifies structures and indications but does not mention genotype-guided use in the provided excerpt.

If you want, I can summarize what is known more broadly (outside these abstracts) about genes involved in phosphate handling (e.g., FGF23/Klotho pathways) and whether any clinically actionable genotype guidance exists; it is not addressed in the text you supplied.

References

  1. Black phosphorus gas sensors.
    Ahmad N Abbas, Bilu Liu, Liang Chen, Yuqiang Ma, Sen Cong, Noppadol Aroonyadet, Marianne Köpf, Tom Nilges, Chongwu Zhou (2015) - ACS nano
  2. Development and Clinical Application of Phosphorus-Containing Drugs.
    Hanxiao Yu, He Yang, Enxue Shi, Wenjun Tang (2020) - Medicine in drug discovery
  3. Dietary macrominerals: Updated review of their role and orchestration in human nutrition throughout the life cycle with sex differences.
    Mohamed A Farag, Bishoy Abib, Zhiwei Qin, Xiaolei Ze, Sara E Ali (2023) - Current research in food science
  4. Phytates as a natural source for health promotion: A critical evaluation of clinical trials.
    Sónia M G Pires, Rita Silva Reis, Susana M Cardoso, Raffaele Pezzani, Esteban Paredes-Osses, Ainur Seilkhan, Alibek Ydyrys, Miquel Martorell, Eda Sönmez Gürer, William N Setzer, Ahmad Faizal Abdull Razis, Babagana Modu, Daniela Calina, Javad Sharifi-Rad (2023) - Frontiers in chemistry
  5. Injectable thermosensitive black phosphorus nanosheet- and doxorubicin-loaded hydrogel for synergistic bone tumor photothermal-chemotherapy and osteogenesis enhancement.
    Shihuai Li, Yunan Qing, Yan Lou, Ruiyan Li, Hao Wang, Xingyue Wang, Boda Ying, Xiongfeng Tang, Yanguo Qin (2023) - International journal of biological macromolecules
  6. Te-Doped Black Phosphorus Field-Effect Transistors.
    Bingchao Yang, Bensong Wan, Qionghua Zhou, Yue Wang, Wentao Hu, Weiming Lv, Qian Chen, Zhongming Zeng, Fusheng Wen, Jianyong Xiang, Shijun Yuan, Jinlan Wang, Baoshun Zhang, Wenhong Wang, Junying Zhang, Bo Xu, Zhisheng Zhao, Yongjun Tian, Zhongyuan Liu (2016) - Advanced materials (Deerfield Beach, Fla.)
  7. Introduction and Executive Summary of the Supplement, Role of Milk and Dairy Products in Health and Prevention of Noncommunicable Chronic Diseases: A Series of Systematic Reviews.
    Ángel Gil, Rosa M Ortega (2019) - Advances in nutrition (Bethesda, Md.)
  8. Effects of Excessive Dietary Phosphorus Intake on Bone Health.
    Colby J Vorland, Elizabeth R Stremke, Ranjani N Moorthi, Kathleen M Hill Gallant (2017) - Current osteoporosis reports
  9. Contributions to total phosphorus intake: all sources considered.
    Mona S Calvo, Jaime Uribarri (2013) - Seminars in dialysis
  10. Brain-Targeted Black Phosphorus-Based Nanotherapeutic Platform for Enhanced Hypericin Delivery in Depression.
    Hanxu Tan, Kerun Cao, Yuying Zhao, Jialong Zhong, Di Deng, Bo Pan, Juping Zhang, Rong Zhang, Zhiyu Wang, Tongkai Chen, Yafei Shi (2024) - Small (Weinheim an der Bergstrasse, Germany)
  11. Use and abuse of dietary supplements in persons with diabetes.
    Bridget A Hannon, William D Fairfield, Bryan Adams, Theodore Kyle, Mason Crow, Diana M Thomas (2020) - Nutrition & diabetes
  12. The emerging role of phosphorus in human health.
    Ranjana P Bird, N A Michael Eskin (2021) - Advances in food and nutrition research
  13. Using Guduchi (Tinospora cordifolia) as an eco-friendly feed supplement in human and poultry nutrition.
    Muhammad Saeed, Muhammad Naveed, Jakob Leskovec, Asgahr Ali Kamboh, Ihsanullah Kakar, Kifayat Ullah, Fawwad Ahmad, Muhammad Sharif, Asif Javaid, Mubasher Rauf, Mohamed E Abd El-Hack, Mervat A Abdel-Latif, Sun Chao (2020) - Poultry science
  14. Recycled Phosphorus Bioamendments from Wastewater Impact Rhizomicrobiome and Benefit Crop Growth: Sustainability Implications at Water-Food Nexus.
    Peisheng He, Yejin Son, Jennifer Berkowitz, Guangyu Li, Jangho Lee, I L Han, Eric Craft, Miguel Piñeros, Jenny Kao-Kniffin, April Z Gu (2025) - Environmental science & technology
  15. Nutritional and ethnomedicinal scenario of koumiss: A concurrent review.
    Muhammad Afzaal, Farhan Saeed, Fatima Anjum, Numra Waris, Muzzamal Husaain, Ali Ikram, Huda Ateeq, Faqir Muhammad Anjum, Hafiz Suleria (2021) - Food science & nutrition
  16. Is phosphorus intake that exceeds dietary requirements a risk factor in bone health?
    Mona S Calvo, Katherine L Tucker (2013) - Annals of the New York Academy of Sciences
  17. Increasing dietary phosphorus intake from food additives: potential for negative impact on bone health.
    Eiji Takeda, Hironori Yamamoto, Hisami Yamanaka-Okumura, Yutaka Taketani (2014) - Advances in nutrition (Bethesda, Md.)
  18. Constructing Interfacial Charge Transfer Channels and Electric Field in Violet Phosphorus-Based van der Waals Heterojunction for Phototherapy of Periodontitis.
    Qian Wu, Tian Deng, Juan Cheng, Yujie Yang, Yulan Wang, Yin Xiao, Yufeng Zhang (2024) - ACS nano
  19. Dietary phosphorus in bone health and quality of life.
    Eiji Takeda, Hironori Yamamoto, Hisami Yamanaka-Okumura, Yutaka Taketani (2012) - Nutrition reviews
  20. Effect of a high phosphorus diet on indicators of renal health in cats.
    Britta Dobenecker, Anna Webel, Sven Reese, Ellen Kienzle (2018) - Journal of feline medicine and surgery


Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!